Health & Wellness Information

Tirzepatide (sold as Mounjaro for type 2 diabetes and Zepbound for weight management) is a once‑weekly injectable medicine that can lower blood sugar and often causes substantial, dose‑dependent weight loss; talk with your clinician about whether it’s right for you.

What tirzepatide is and how it works

Tirzepatide is a medicine that acts on two gut hormones (GIP and GLP‑1) to help your body release insulin when blood sugar is high, lower glucagon, slow stomach emptying, and reduce appetite. It is approved by the FDA for type 2 diabetes (Mounjaro) and for chronic weight management (Zepbound) in adults who meet the criteria.  Food and Drug Administration (.gov)  accessdata.fda.gov

What patients commonly experience

• How it’s given: a once‑weekly subcutaneous (under the skin) injection using a prefilled pen.  accessdata.fda.gov
• Typical effects: clinical trials showed large average weight losses (for example, in SURMOUNT‑1 participants without diabetes, mean weight loss at 72 weeks was about 15% with 5 mg, 19.5% with 10 mg, and 20.9% with 15 mg), and meaningful improvements in blood sugar for people with type 2 diabetes.  The New England Journal of Medicine  ClinicalTrials.gov
• Longer outcomes: longer follow‑up data show sustained weight reduction and fewer new cases of type 2 diabetes among people with prediabetes who used tirzepatide.  dloveveryclinic.com

Common side effects and safety points

• Most common: nausea, vomiting, diarrhea, constipation, decreased appetite, and injection‑site reactions. These are usually worse during dose increases and often improve over time.  accessdata.fda.gov
• Serious but uncommon risks: pancreatitis and gallbladder problems have been reported; there is a boxed warning about thyroid C‑cell tumors in rodents, so tirzepatide is not used in people with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2. Discuss any history of pancreatitis, thyroid cancer, or other serious conditions with your clinician.  accessdata.fda.gov

Who should not take it or should use caution

• Not for type 1 diabetes.
• Avoid if you have a personal or family history of MTC or MEN2.
• Use caution with a history of pancreatitis, severe gastrointestinal disease, or during pregnancy and breastfeeding because safety is not established. Always tell your provider about all medicines you take, especially insulin or sulfonylureas, because dose adjustments may be needed to avoid low blood sugar.  accessdata.fda.gov

Practical tips and next steps

• Talk with your healthcare provider about whether tirzepatide is appropriate for you, how it would fit with your other medicines, and how to manage side effects.
• Expect a titration plan (gradual dose increases) to reduce GI side effects; your prescriber will explain the schedule and monitoring.  accessdata.fda.gov
• Combine with lifestyle changes (healthy eating, physical activity) for best results. Clinical trials paired medication with lifestyle support.  The New England Journal of Medicine

Semaglutide (brand names Ozempic for diabetes and Wegovy for weight management) is a once‑weekly injectable medicine that lowers blood sugar and can produce substantial, sustained weight loss; talk with your clinician to see if it’s appropriate for you.

Semaglutide is a GLP‑1 receptor agonist that helps your body release insulin when blood sugar is high, slows stomach emptying, and reduces appetite. It is FDA‑approved for treatment of type 2 diabetes (marketed as Ozempic and other formulations) and for chronic weight management (marketed as Wegovy). Wegovy also has an FDA indication to reduce the risk of major cardiovascular events in adults with established heart disease and excess weight.  accessdata.fda.govaccessdata.fda.gov

How it works (in plain language)

Semaglutide mimics a natural gut hormone (GLP‑1). That action helps lower blood sugar after meals and makes you feel fuller, which often leads to weight loss. These effects are strongest when the medicine is combined with diet and increased physical activity.  accessdata.fda.gov

What people commonly experience

• How it’s given: a once‑weekly injection under the skin (abdomen, thigh, or upper arm) using a prefilled pen. Your prescriber will explain how to use the device.  accessdata.fda.gov
• Typical benefits: many people see meaningful reductions in blood sugar and clinically significant weight loss when used with lifestyle changes; higher doses have produced larger average weight losses in clinical trials. accessdata.fda.gov  Food and Drug Administration (.gov)

Common side effects and safety points

• Most common: nausea, vomiting, diarrhea, constipation, and injection‑site reactions; these are usually worse when the dose is being increased and often improve over time.  accessdata.fda.gov
• Serious but uncommon risks: pancreatitis and gallbladder problems have been reported. Semaglutide carries a boxed warning about thyroid C‑cell tumors seen in rodents; it is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2). accessdata.fda.gov

Who should not take it or should use caution

• Not for people with type 1 diabetes.
• Avoid if you have a personal or family history of MTC or MEN2.
• Tell your clinician if you have a history of pancreatitis, severe gastrointestinal disease, or are pregnant or breastfeeding, since safety in pregnancy and lactation is not established. Also tell them about all other medicines you take because some combinations can increase the risk of low blood sugar.  accessdata.fda.gov

Practical tips for patients

• Talk with your clinician about goals, expected benefits, side effects, and how you’ll be monitored.
• Expect a gradual dose‑increase plan to reduce side effects; follow the schedule your prescriber gives you. accessdata.fda.gov
• Combine medication with dietary changes and physical activity for the best results.
• Ask your pharmacist or clinician about cost, insurance coverage, and patient‑support programs; availability and pricing can change over time.  Food and Drug Administration (.gov)

Liraglutide (Victoza for type 2 diabetes; Saxenda for weight management) is a once‑daily injectable medicine that lowers blood sugar and can help with sustained weight loss when combined with diet and activity — talk with your clinician to see if it’s right for you.  accessdata.fda.gov  accessdata.fda.gov

Liraglutide is a GLP‑1 receptor agonist that mimics a natural gut hormone to increase insulin release when blood sugar is high, reduce glucagon, slow stomach emptying, and decrease appetite. It is FDA‑approved as Victoza for type 2 diabetes (including a cardiovascular risk reduction indication in people with T2D and established CVD) and as Saxenda for chronic weight management in adults and some pediatric patients.  accessdata.fda.gov  accessdata.fda.gov

How it’s given (plain language)

• Route and frequency: Liraglutide is given as a once‑daily subcutaneous injection (abdomen, thigh, or upper arm) using a prefilled pen.
• Titration: Treatment usually starts at a low dose for one week and is increased stepwise to the target dose to reduce side effects; the recommended Saxenda maintenance dose for weight management is 3 mg daily, while Victoza dosing for diabetes is titrated up to 1.8 mg daily as needed.  accessdata.fda.gov  accessdata.fda.gov

What people commonly experience

• Benefits: Many people see improvements in blood sugar control and reduced appetite; when used for weight management alongside diet and exercise, liraglutide can produce clinically meaningful weight loss.
• Common side effects: Nausea, vomiting, diarrhea, constipation, decreased appetite, and injection‑site reactions are the most frequent and are often worse during dose increases but tend to improve over time. accessdata.fda.gov

Important safety warnings and who should use caution

• Thyroid tumor warning: Liraglutide carries a boxed warning because thyroid C‑cell tumors occurred in rodent studies; it is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC)or Multiple Endocrine Neoplasia type 2 (MEN2).
• Other cautions: Tell your clinician if you have a history of pancreatitis, severe gastrointestinal disease, or are pregnant or breastfeeding; discuss all medicines you take because interactions and hypoglycemia risk (when combined with insulin or sulfonylureas) may require monitoring or dose changes. Seek immediate care for severe abdominal pain or persistent vomiting.  accessdata.fda.gov  accessdata.fda.gov

Practical tips for patients

• Learn injection technique from your clinician or pharmacist and rotate injection sites.
• Follow the titration schedule your prescriber gives you to reduce GI side effects.

Contrave (naltrexone + bupropion) is an oral medicine used with diet and exercise to help adults with overweight or obesity lose weight; it can help reduce appetite and cravings but has important safety warnings—talk with your clinician before starting.

Contrave combines two medicines (naltrexone and bupropion) that work on brain pathways involved in appetite, reward, and cravings. It is prescribed as an adjunct to a reduced‑calorie diet and increased physical activity for chronic weight management in adults with obesity or overweight plus at least one weight‑related condition. accessdata.fda.gov

How it’s taken (plain language)

Contrave is a prescription oral tablet taken twice daily after a gradual start‑up period so your body can adjust. Your prescriber will explain a stepwise schedule to reach the dose intended for long‑term use. Follow their instructions and do not combine Contrave with other products that contain bupropion or naltrexone.  accessdata.fda.gov

What people commonly experience

• Common side effects: nausea, constipation, headache, dry mouth, and trouble sleeping are among the more frequent complaints.  DailyMed
• Behavioral and mood effects: because bupropion is an antidepressant component, mood changes, depression, or suicidal thoughts have been reported; monitoring for new or worsening psychiatric symptoms is required. accessdata.fda.gov  start.contrave.com

Major safety warnings and who should not take it

• Boxed warning for suicidal thoughts and behaviors in children, adolescents, and young adults taking antidepressants; watch for mood changes and seek help immediately if they occur.  accessdata.fda.gov
• Do not take Contrave if you have uncontrolled high blood pressure, a seizure disorder, an eating disorder (like bulimia or anorexia nervosa), are undergoing abrupt alcohol or sedative withdrawal, are using chronic opioids, or are taking other bupropion‑containing products or MAO inhibitors. Tell your clinician about all medicines you take.  accessdata.fda.gov  DailyMed

Important interactions and precautions

• Opioids: because naltrexone blocks opioid effects, Contrave can precipitate withdrawal in people using opioids and can interfere with pain control.  accessdata.fda.gov
• Seizure risk: bupropion can lower the seizure threshold; avoid if you have a seizure disorder or certain eating disorders.  accessdata.fda.gov

Practical tips for patients

• Follow the prescribed titration schedule and keep regular follow‑up visits to check blood pressure, mood, and side effects.  accessdata.fda.gov
• Report any new or worsening depression, suicidal thoughts, or unusual behavior immediately.accessdata.fda.gov
• Use Contrave only with a comprehensive plan that includes diet, physical activity, and medical follow‑up. accessdata.fda.gov

Talk with your healthcare provider before starting Contrave to review your medical history, current medicines, pregnancy plans, and a monitoring plan. If you want, I can make a short list of questions to bring to your clinician (e.g., about interactions, what to watch for, and follow‑up checks).  accessdata.fda.gov  accessdata.fda.gov

Qsymia is a prescription oral medicine (phentermine + topiramate extended‑release) used with diet and exercise to help adults with overweight or obesity lose weight; it can be effective but carries important safety warnings—talk with your clinician before starting.

Qsymia combines phentermine (an appetite suppressant) and topiramate (which reduces appetite and may increase feelings of fullness) to support chronic weight management in adults with obesity or overweight plus weight‑related conditions. It is prescribed as part of a comprehensive plan that includes diet, activity, and medical follow‑up.  accessdata.fda.gov  Qsymia

How it’s taken (plain language)

Qsymia is an oral capsule taken once daily after a gradual start‑up schedule your prescriber will explain. Because of safety concerns, it is dispensed only through certified pharmacies under a REMS (Risk Evaluation and Mitigation Strategy) for pregnancy prevention and monitoring.  Food and Drug Administration (.gov)  dev.qsymiarems.com

What people commonly experience

• Common side effects: tingling or numbness (paresthesia), constipation, dry mouth, insomnia, dizziness, and changes in taste or memory. Many side effects are most noticeable during dose changes.  accessdata.fda.gov
• Typical benefits: people taking Qsymia alongside lifestyle changes often lose more weight than with lifestyle changes alone; individual results vary and depend on adherence and follow‑up.  Food and Drug Administration (.gov)

Serious warnings — what to know and watch for

• Birth defects: Topiramate is linked to an increased risk of oral clefts (cleft lip/palate) if taken during pregnancy.Women who can become pregnant must have a negative pregnancy test before starting and monthly while taking Qsymia, and use effective contraception. If pregnancy occurs, stop Qsymia immediately. Because of this risk, Qsymia is available only through a REMS program.  Qsymia  Food and Drug Administration (.gov)
• Mental health: topiramate may increase the risk of suicidal thoughts or behavior; report new or worsening depression, anxiety, or suicidal thoughts right away.  accessdata.fda.gov
• Heart rate and eye problems: Qsymia can increase resting heart rate and has been associated with serious eye problems (sudden vision changes, angle‑closure glaucoma); report chest palpitations or sudden vision changes. accessdata.fda.gov

Who should not take Qsymia or should use caution

Do not take Qsymia if you are pregnant. Tell your clinician if you have a history of glaucoma, hyperthyroidism, recent stroke or heart disease, uncontrolled high blood pressure, or a history of suicidal thoughts. Discuss all medicines you take because interactions and side effects can be serious.  accessdata.fda.gov

Practical tips for patients

• Follow the titration schedule and monthly pregnancy testing if applicable.  Qsymia
• Keep regular follow‑up visits to monitor weight, heart rate, mood, and side effects.
• Stop and seek care for severe abdominal pain, sudden vision loss, chest pain, or new suicidal thoughts.

Questions to bring to your clinician

• Why do you recommend Qsymia for me?
• How will we monitor pregnancy risk, mood, heart rate, and vision?
• What should I do if I miss a dose or experience side effects?

Talk with your healthcare provider before starting Qsymia to review your medical history, pregnancy plans, and a monitoring plan tailored to you.  Food and Drug Administration (.gov)  accessdata.fda.gov

Lomaira (phentermine) is a short‑term prescription appetite suppressant taken as a small oral tablet to help with weight loss when used with diet and exercise; talk with your clinician to see if it’s safe and appropriate for you.

Lomaira contains phentermine, a sympathomimetic amine that reduces appetite by stimulating the central nervous system. It is prescribed short‑term (a few weeks) as part of a comprehensive weight‑loss plan for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight‑related condition. Lomaira is intended to be used together with diet, exercise, and medical follow‑up.  lomaira.com  DailyMed

How it’s taken (plain language)

• Form and frequency: Lomaira is an 8 mg oral tablet; dosing is typically multiple times per day as directed by your prescriber for short‑term use. Follow the exact schedule your clinician gives you.  NDC List  DailyMed
• Duration: It is not intended for long‑term use without reassessment; your clinician will decide how long it’s appropriate.  lomaira.com

What people commonly experience

• Common side effects: dry mouth, insomnia, dizziness, constipation, increased heart rate, and nervousness. These effects are related to central nervous system stimulation.  DailyMed  Drugs.com
• Serious but uncommon risks: increased blood pressure, palpitations, shortness of breath, chest pain, and potential for dependence or abuse. Report any chest pain, fainting, or sudden shortness of breath immediately.  DailyMedlomaira.com

Who should NOT take Lomaira or should use caution

• Do not use if you have severe heart disease, uncontrolled high blood pressure, history of stroke, glaucoma, hyperthyroidism, agitation, or a history of drug abuse. Do not combine with MAO inhibitors or other stimulant weight‑loss drugs. Lomaira is contraindicated in pregnancy; weight loss during pregnancy can harm the baby. lomaira.com  DailyMed
• Use caution if you have kidney problems, are older, or take other medications that raise blood pressure or affect the heart.  NDC List

Important interactions and safety notes

• Drug interactions: Tell your clinician about all medicines, supplements, and recreational drugs you use—Lomaira can interact with MAO inhibitors and other stimulants.  DailyMed
• Tolerance and monitoring: Appetite‑suppressant effects may decrease over time (tolerance). Your clinician will monitor blood pressure, heart rate, and overall response and will stop the medicine if risks outweigh benefits.  NDC List

Practical tips for patients

• Take exactly as prescribed and do not increase dose on your own.
• Avoid alcohol and other stimulants while taking Lomaira.
• Report new chest pain, shortness of breath, fainting, severe headache, vision changes, or mood/behavior changes immediately.
• Discuss pregnancy plans—do not use Lomaira if pregnant or trying to become pregnant.  lomaira.com  Drugs.com

Metformin is a commonly prescribed oral medicine used to treat type 2 diabetes and sometimes used off‑label for conditions such as prediabetes or polycystic ovary syndrome (PCOS). It helps lower blood sugar and is often a first‑line treatment. Talk with your healthcare provider before starting or stopping metformin.

• What it does: Metformin lowers blood sugar primarily by reducing how much glucose your liver makes and by helping your body use insulin more effectively.
• Why it’s used: It is used to improve blood sugar control in people with type 2 diabetes and may help with modest weight stabilization or modest weight loss in some people when combined with diet and exercise.

How it’s taken and what to expect

• Form and frequency: Metformin is a pill taken by mouth. There are different formulations (immediate‑release and extended‑release) and your clinician will choose the one that fits you best.
• When to take it: Many people take metformin with meals to reduce stomach upset. Follow the instructions your prescriber or pharmacist gives you.
• Onset of effect: Blood sugar improvements are usually seen over days to weeks; your provider will monitor blood tests to see how well it’s working.

Common side effects and what helps

• Most common: stomach upset, nausea, diarrhea, and abdominal discomfort. These side effects are often worse when you first start or when the dose is changed and frequently improve over time.
• Ways to reduce GI side effects: taking metformin with food, using the extended‑release form if recommended, and following the titration plan your clinician provides can help. Do not change the dose on your own.

Important safety points and warnings

• Kidney function: metformin is generally avoided or used with caution in people with significantly reduced kidney function. Your clinician will check kidney tests before and during treatment.
• Lactic acidosis: a rare but serious condition called lactic acidosis can occur in people with severe kidney, liver, or heart problems or in certain acute illnesses. Seek urgent care for unexplained severe weakness, muscle pain, trouble breathing, dizziness, or stomach pain with vomiting.
• Vitamin B12: long‑term metformin use can reduce vitamin B12 levels in some people; your clinician may check B12 periodically and recommend supplements if needed.
• Contrast studies and surgery: your clinician may advise temporarily stopping metformin before certain imaging tests that use iodinated contrast or before some surgeries; follow their instructions.
• Pregnancy and breastfeeding: metformin is sometimes used in pregnancy for gestational diabetes or PCOS but discuss risks and benefits with your clinician if you are pregnant, planning pregnancy, or breastfeeding.

Drug interactions and things to tell your clinician

• Tell your clinician about all medicines, supplements, and herbal products you take, especially medicines that affect kidney function or cause dehydration.
• Alcohol: limit excessive alcohol because it can increase the risk of lactic acidosis and worsen side effects.
• Insulin or sulfonylureas: if you use other diabetes medicines that lower blood sugar, your clinician may need to adjust doses to reduce the risk of low blood sugar.

Practical tips for patients

• Take metformin exactly as prescribed and do not stop it suddenly without talking to your clinician.
• Keep routine lab checks (kidney tests, blood sugar monitoring, and possibly B12) as recommended.
• Report symptoms such as severe abdominal pain, persistent vomiting, sudden shortness of breath, extreme weakness, or fainting right away.
• Combine medication with lifestyle changes (healthy eating, physical activity, weight management) for the best results.

Foundayo (orforglipron) is an FDA‑approved, once‑daily oral GLP‑1 receptor agonist for chronic weight management that produced dose‑dependent, clinically meaningful weight loss in 72‑week trials; talk with your clinician about whether an oral GLP‑1 pill is right for you.  Drugs.com

Foundayo (generic: orforglipron) is an oral, small‑molecule GLP‑1 receptor agonist developed for chronic weight management in adults with obesity or overweight plus weight‑related conditions. It mimics the gut hormone GLP‑1 to reduce appetite and slow gastric emptying, helping people eat less and lose weight.  Drugs.com  WebMD

How it’s given

• Form: oral tablet taken once daily.
• Dosing: starts low and is titrated upward (available tablet strengths include 0.8 mg up to 17.2 mg). Foundayo can be taken with or without food and at any time of day.  WebMD  Medical News Today

Typical effects seen in trials

• Dose‑dependent weight loss: In 72‑week trials of adults without diabetes, average weight loss ranged from ~7.4% (5.5 mg) to ~11.1% (17.2 mg) versus ~2.1% with placebo. Higher doses produced larger mean weight reductions. foundayo.lilly.com  Drugs.com
• Cardiometabolic improvements: Trials reported improvements in waist circumference, non‑HDL cholesterol, triglycerides, and systolic blood pressure.  Drugs.com

Common side effects and safety points

• Most common: nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, headache, fatigue, and hair loss; these often occur during dose escalation and tend to improve over time.  WebMD  Medical News Today
• Serious but uncommon risks: boxed warning for thyroid C‑cell tumors observed in rodents; do not use if you or a family member has medullary thyroid carcinoma (MTC) or MEN2. Discuss any history of pancreatitis or severe GI disease with your clinician.  foundayo.lilly.com  Medical News Today

Who should not take it or should use caution

• Not for people with a personal or family history of MTC or MEN2.  foundayo.lilly.com
• Use caution in pregnancy and breastfeeding (safety not established), with a history of pancreatitis, or when combining with other glucose‑lowering drugs that can cause hypoglycemia; always tell your provider about all medicines you take.  WebMD  Medical News Today

Practical tips and next steps

• Talk with your healthcare provider about whether Foundayo fits your medical history, other medications, and weight‑management goals. Expect a gradual titration plan to reduce GI side effects.  Medical News Today
• Do not combine Foundayo with other GLP‑1 receptor agonists unless directed by a specialist.  foundayo.lilly.com
• Combine medication with dietary changes and increased physical activity for best results; discuss monitoring and follow‑up plans with your clinician.  Drugs.com

Orlistat is a medicine that helps with weight loss by reducing the amount of fat your body absorbs from food. It is available as a prescription product (Xenical) and a lower‑dose over‑the‑counter product (Alli). Orlistat is used together with a reduced‑calorie, lower‑fat diet and increased physical activity. Talk with your clinician to see if it’s appropriate for you.

How orlistat works in plain language

Orlistat blocks enzymes in your gut that break down dietary fat. Because some fat passes through your digestive tract undigested, you absorb fewer calories from fatty foods. To work best and reduce side effects, orlistat should be used with a balanced, reduced‑calorie diet that is not high in fat.

How it’s taken and what to expect

• Form and timing: Orlistat is taken by mouth with meals that contain fat. If a meal is skipped or contains no fat, the dose is usually skipped.
• Combination with lifestyle: It is intended to be used as part of a comprehensive plan that includes diet changes and physical activity.
• Onset of effect: Weight loss may begin within weeks; results vary by person and depend on adherence to diet and activity changes.

Common side effects and how to manage them

• Most common: oily or fatty stools, urgent bowel movements, increased flatulence, and more frequent bowel movements. These effects are caused by unabsorbed fat and are more likely when meals are high in fat.
• How to reduce GI side effects: follow a lower‑fat diet, spread fat intake across meals, and avoid large high‑fat meals. If GI side effects are severe or persistent, contact your clinician.
• Nutrient considerations: orlistat can reduce absorption of fat‑soluble vitamins (A, D, E, K) and beta‑carotene. Your clinician or pharmacist may recommend a daily multivitamin taken at a different time of day (for example, at bedtime) while using orlistat.

Important safety warnings and who should not take it

• Do not use orlistat if you are pregnant. Weight loss is not recommended during pregnancy.
• Avoid if you have chronic malabsorption syndrome (a condition that already prevents nutrient absorption) or cholestasis (a liver/bile flow problem).
• Tell your clinician if you have liver disease, gallbladder disease, kidney stones, or take medications that require fat for absorption.
• Drug interactions: because orlistat can affect absorption of some medicines and vitamins, review all your medicines and supplements with your clinician or pharmacist.

When to call your clinician or seek urgent care

• Severe abdominal pain, persistent vomiting, or signs of liver problems (dark urine, yellowing of the skin or eyes, severe fatigue).
• Signs of malnutrition, unusual bruising, or symptoms suggesting vitamin deficiency (night blindness, easy bruising, numbness).
• If you become pregnant while taking orlistat.

Practical tips for patients

• Follow a reduced‑calorie, lower‑fat eating plan to improve results and reduce side effects.
• Take a daily multivitamin containing fat‑soluble vitamins at a different time than orlistat, as advised by your clinician.
• Keep a food and symptom diary for the first few weeks to identify high‑fat meals that trigger side effects.
• Discuss cost and availability with your pharmacist; over‑the‑counter and prescription options differ.
• Follow up with your clinician to review weight progress, side effects, and whether continued treatment is appropriate.